Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

Crispr Therapeutics AG

NASDAQ: CRSP · Life Sciences · 9 alerts · CIK 1674416

Share price
$40.37Close, Nov 16
Market cap
$3.92B
Shares outstanding
97MLatest SEC cover page
Sector
Life Sciences
Industry
Biological Products, (No Diagnostic Substances)SIC 2836

Today's reference numbers: shares from the company's latest SEC cover page, price from the latest market close. Not a valuation or a recommendation. All Crispr Therapeutics AG filings on SEC EDGAR ↗

5:35 PM ET Form 4
Insider Selling

Crispr Therapeutics CEO Samarth Kulkarni Sells $2.38M of Stock

Samarth Kulkarni, CEO, sold 47,837 shares of Crispr Therapeutics AG at $49.78 a share, worth $2.38M in total on Oct 19, 2026. Shares held after the trade: 311,899 (-13.3%).

Value
$2.38M
Shares
47,837
Price
$49.78
Role
CEO
Holding change
-13.3%
Trade date
Oct 19, 2026

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.